Pfizer vaccines works on the covid 19 variant found in the india
•Download as PPTX, PDF•
0 likes•77 views
Pfizer has confirmed this new by announcing that their vaccine shows high efficacy towards the COVIS-19 variant found in the India
Report
Share
Report
Share
Recommended
Covid-19 Vaccine Market Rally
Markets around the globe are rallying on news that Pfizer’s Covid-19 vaccine is more than 90% effective in preventing the disease. How can you best profit from the Covid-19 vaccine market rally?
https://youtu.be/G6Zd-uFbCNU
COVID-19 Vaccine Deals
The COVID-19 vaccine race is progressing rapidly, with a handful of candidates already entering Phase 3 clinical trials in Q3 2020. Deals are being struck between developed nations and the top vaccine developers to secure doses even before FDA approval. Coalitions & alliances are also being set up to ensure vaccine access for lower-income countries.
We Analyzed 1 Million Articles about Covid Vaccines. Here’s What We Found!
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Ever since The World Health Organization (WHO) declared the Coronavirus outbreak as a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020, scientists from all over the world have been scrambling to create a vaccine.
During this period, vaccine development was expedited and scientists faced various challenges in creating a working vaccine.
The urgency to create a vaccine led to “compressed schedules” where trials for vaccines, which usually take years, were conducted over a period of months.
Since then, Several vaccines have been approved for mass vaccination drives against COVID-19 and have been distributed globally.
However, the community’s knowledge, attitudes, and perceptions towards these vaccinations are poorly understood.
We analyzed 1M articles that contained the mentions of various vaccines and here’s what we found.
✔✔ Conversations about Pfizer have received more engagement on Twitter as Pfizer has shown the highest efficacy rate of 95%.
✔✔ Moderna has an efficacy of 94.1% against covid infection and the engagement shows that articles that mention Moderna had lesser engagement than Pfizer but considerably more than other vaccines.
✔✔ AstraZeneca ranks third when it comes to Twitter engagement among popular vaccines.
✔✔ Russia’s Sputnik vaccine claims a 95% efficacy rate, even before beginning a Phase III trial. But conversations and engagement on Twitter have been minimal.
✔✔ Covaxin and Novavax have had some conversations and mentions on Twitter, unlike Janssen, a vaccine that has had the least engagement.
You can find more interesting data in our report!
Covid 19 vaccine safety and efficacy
The document discusses lipid nanoparticles containing COVID-19 spike proteins, the approval process for COVID-19 vaccines, and Phase 3 trial results for the Pfizer/BioNTech and Moderna vaccines. It provides details on the FDA approval process, including Phase 1-3 clinical trials involving thousands of volunteers to test safety and efficacy. Phase 3 trials for the Pfizer and Moderna vaccines showed 95% and 94.5% efficacy respectively in preventing symptomatic COVID-19 based on large randomized controlled trials.
(EN) 2021 COVID-19 Vaccines Social Buzz Insight Report [SM2Networks]
This is a report that analyzes the responses and reputations of the COVID-19 vaccines by country.
We conducted in-depth data analysis such as engagement and correlation as well as simple quantitative analysis of social data generated in Korea, China, Japan and 7 countries with a large number of coronavirus confirmed cases.
If you have any questions about this report, please contact the SM2Networks Marketing Intelligence Team.
Web : www.sm2marketing.co.kr
E-mail : marketing@samhwa.com
Blog_1: https://blog.naver.com/synthesio
Blog_2 : https://blog.naver.com/dmktginsight
Tel : 031-478-1570
#COVID19 #coronavirus #corona vaccine #coronavirus vaccine #COVID vaccine #pfizer #astrazeneca #moderna #sinovac #sinopharm #janssen #novavax
Progress on COVID-19 Vaccine Development
The document discusses progress on COVID-19 vaccine development. It outlines the typical vaccine development process, including exploratory, pre-clinical, clinical trial, and regulatory approval stages. For COVID-19 vaccines, 28 candidates are currently in clinical trials, with 6 in Phase III. Two vaccines have received limited or early approval - one by China and one by Russia, though the WHO has not yet approved any vaccine. It may still take 12-18 months to develop an approved vaccine. Continued preventative measures are still needed while vaccine development progresses.
Vaccines myths and facts extended
Vaccines have been very successful in eradicating devastating diseases, but this success means few people have seen the harms of these diseases firsthand. As a result, attention has shifted to perceived vaccine risks. Common myths include concerns about side effects, the vaccines being developed too quickly, and that the mRNA technology is too new. However, the document explains that potential side effects indicate the immune system is working as intended, no standards were broken during testing, and mRNA technology has been studied for a decade. Overall, the document aims to ease hesitancy by addressing myths and emphasizing vaccine safety and importance for community protection.
Course vaccines myths and facts (corto)
This document addresses common myths about the COVID-19 vaccine by providing facts. It discusses that most side effects are minor and indicate an immune response is working, and that no serious side effects have been reported in millions vaccinated. It also notes that vaccines were not developed too quickly and still underwent rigorous testing and review by experts. New vaccine technologies being used have been studied for over a decade for other uses as well. The document concludes the vaccine is shown to be safe and effective in reducing COVID-19 risks and allows for population immunity benefits.
Recommended
Covid-19 Vaccine Market Rally
Markets around the globe are rallying on news that Pfizer’s Covid-19 vaccine is more than 90% effective in preventing the disease. How can you best profit from the Covid-19 vaccine market rally?
https://youtu.be/G6Zd-uFbCNU
COVID-19 Vaccine Deals
The COVID-19 vaccine race is progressing rapidly, with a handful of candidates already entering Phase 3 clinical trials in Q3 2020. Deals are being struck between developed nations and the top vaccine developers to secure doses even before FDA approval. Coalitions & alliances are also being set up to ensure vaccine access for lower-income countries.
We Analyzed 1 Million Articles about Covid Vaccines. Here’s What We Found!
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Ever since The World Health Organization (WHO) declared the Coronavirus outbreak as a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020, scientists from all over the world have been scrambling to create a vaccine.
During this period, vaccine development was expedited and scientists faced various challenges in creating a working vaccine.
The urgency to create a vaccine led to “compressed schedules” where trials for vaccines, which usually take years, were conducted over a period of months.
Since then, Several vaccines have been approved for mass vaccination drives against COVID-19 and have been distributed globally.
However, the community’s knowledge, attitudes, and perceptions towards these vaccinations are poorly understood.
We analyzed 1M articles that contained the mentions of various vaccines and here’s what we found.
✔✔ Conversations about Pfizer have received more engagement on Twitter as Pfizer has shown the highest efficacy rate of 95%.
✔✔ Moderna has an efficacy of 94.1% against covid infection and the engagement shows that articles that mention Moderna had lesser engagement than Pfizer but considerably more than other vaccines.
✔✔ AstraZeneca ranks third when it comes to Twitter engagement among popular vaccines.
✔✔ Russia’s Sputnik vaccine claims a 95% efficacy rate, even before beginning a Phase III trial. But conversations and engagement on Twitter have been minimal.
✔✔ Covaxin and Novavax have had some conversations and mentions on Twitter, unlike Janssen, a vaccine that has had the least engagement.
You can find more interesting data in our report!
Covid 19 vaccine safety and efficacy
The document discusses lipid nanoparticles containing COVID-19 spike proteins, the approval process for COVID-19 vaccines, and Phase 3 trial results for the Pfizer/BioNTech and Moderna vaccines. It provides details on the FDA approval process, including Phase 1-3 clinical trials involving thousands of volunteers to test safety and efficacy. Phase 3 trials for the Pfizer and Moderna vaccines showed 95% and 94.5% efficacy respectively in preventing symptomatic COVID-19 based on large randomized controlled trials.
(EN) 2021 COVID-19 Vaccines Social Buzz Insight Report [SM2Networks]
This is a report that analyzes the responses and reputations of the COVID-19 vaccines by country.
We conducted in-depth data analysis such as engagement and correlation as well as simple quantitative analysis of social data generated in Korea, China, Japan and 7 countries with a large number of coronavirus confirmed cases.
If you have any questions about this report, please contact the SM2Networks Marketing Intelligence Team.
Web : www.sm2marketing.co.kr
E-mail : marketing@samhwa.com
Blog_1: https://blog.naver.com/synthesio
Blog_2 : https://blog.naver.com/dmktginsight
Tel : 031-478-1570
#COVID19 #coronavirus #corona vaccine #coronavirus vaccine #COVID vaccine #pfizer #astrazeneca #moderna #sinovac #sinopharm #janssen #novavax
Progress on COVID-19 Vaccine Development
The document discusses progress on COVID-19 vaccine development. It outlines the typical vaccine development process, including exploratory, pre-clinical, clinical trial, and regulatory approval stages. For COVID-19 vaccines, 28 candidates are currently in clinical trials, with 6 in Phase III. Two vaccines have received limited or early approval - one by China and one by Russia, though the WHO has not yet approved any vaccine. It may still take 12-18 months to develop an approved vaccine. Continued preventative measures are still needed while vaccine development progresses.
Vaccines myths and facts extended
Vaccines have been very successful in eradicating devastating diseases, but this success means few people have seen the harms of these diseases firsthand. As a result, attention has shifted to perceived vaccine risks. Common myths include concerns about side effects, the vaccines being developed too quickly, and that the mRNA technology is too new. However, the document explains that potential side effects indicate the immune system is working as intended, no standards were broken during testing, and mRNA technology has been studied for a decade. Overall, the document aims to ease hesitancy by addressing myths and emphasizing vaccine safety and importance for community protection.
Course vaccines myths and facts (corto)
This document addresses common myths about the COVID-19 vaccine by providing facts. It discusses that most side effects are minor and indicate an immune response is working, and that no serious side effects have been reported in millions vaccinated. It also notes that vaccines were not developed too quickly and still underwent rigorous testing and review by experts. New vaccine technologies being used have been studied for over a decade for other uses as well. The document concludes the vaccine is shown to be safe and effective in reducing COVID-19 risks and allows for population immunity benefits.
What's in the COVID-19 vaccines?
Description of active and inactive ingredient of COVID-19 vaccine, Pfizer BioNTech, Moderna and AstraZeneca vaccine covered
Coronavirus Pandemic Part III (C): Vaccines (rev01)
In this section of the coronavirus pandemic series, we discuss the need for an effective COVID-19 vaccine to return to full normalcy. The slides would give a brief overview on how our immune systems work, and how a vaccine would train our immune system to recognize and fight the infection. Current vaccine platform technologies will be compared, and upcoming candidates will be highlighted for newer-generation vaccines. We'll also discuss in-depth on factors involving vaccine manufacturing, hesitancy & acceptance, and contingencies. The market capitalization of pharma companies involved in the development of the coronavirus vaccine will also be compared.
Vaccines myths and facts (short)
This document addresses common myths about the COVID-19 vaccine by providing facts. It discusses that most side effects are minor and indicate an immune response is being generated. It also notes that no serious side effects have been reported in the millions vaccinated globally. Additionally, it states that the vaccine development process was not shortened and all usual FDA standards were met, and the mRNA technology used has been studied for over a decade. The document concludes the vaccine is shown to be safe and effective at reducing COVID-19 transmission and chances of catching the virus.
COVID-19 Therapeutics Update (End Q1 2021)
These slides highlight the approved & widely used therapeutics for treating COVID-19 patients (end Q1 2021). At the time of writing, there are 5 therapeutics that have been granted Emergency Use Authorization by the US FDA, mostly being antivirals and monoclonal antibodies (mAbs). The use of corticosteroids and cytokine inhibitors are also showing promise in their ability to reduce case fatalities, progression as well as hospitalization time.
Γρηγόρης Ντάκουλας, 4th Health Innovation Conference
Ομιλία – Παρουσίαση: Γρηγόρης Ντάκουλας, Medical Director AstraZeneca Ελλάδος
Τίτλος: «H AstraZeneca στη μάχη ενάντια στον SARS CoV-2»
SUBTOPIC: COVID- 19 vaccine CRITERIA, BENEFITS
The document summarizes the development process for COVID-19 vaccines. It notes that vaccine development usually takes years but the pandemic spurred over 100 candidates in rapid development. It outlines the typical stages: exploratory research, pre-clinical testing, clinical trials in three phases, regulatory review, quality control, and approval. The document also provides information on COVAXIN, an approved COVID-19 vaccine in India, including its ingredients, administration method, benefits, side effects, and effectiveness based on clinical trials.
Vaccines updates1
There are several types of vaccines in development for COVID-19 because having multiple approaches increases the chances of success. The document discusses live-attenuated, inactivated, subunit, viral vector, and nucleic acid vaccines. Each uses different technologies to prompt an immune response through exposure to part or all of the virus or by delivering genetic instructions for the body to make viral proteins. Understanding the variety of vaccine types being studied can help explain why there are so many candidates under evaluation.
COVID-19 Vaccines Update (End Q1 2021)
These slides highlight the approved & widely used vaccines for immunization against COVID-19 (as of end Q1 2021). At the time of writing, there are 3 COVID-19 vaccines that have been granted Emergency Use Authorization by the US FDA, 2 of which are using mRNA platforms.
Covid 19 Vaccines
In this presentation, we discuss the clinical trial process for the new Covid-19 vaccines. We discuss the different vaccine types. We also discuss the Covid-19 vaccines that the UK is currently using in the NHS, as well as vaccines likely to be used in the next year.
The Future Landscape of Covid-19 Vaccine Market
We believe that assessing the potential market for COVID-
19 vaccines is necessary in terms of reevaluating the risk/reward ratio of certain vaccine developing companies.
In addition, an overly utopian outlook for a potential COVID-19 vaccine market may lead to
disappointment and negatively affect future vaccine developers. And this concerns us more.
Know your COVID-19 Vaccine (Philippines)
The content aims to contribute spreading right information about COVID-19 Vaccine. The information are from World Health Organization and Philippine Department of Health. This may help my fellow Filipino to build his/her confidence to get vaccinated.
Developing Drug against COVID-19
This document discusses developing a new antiviral drug to treat COVID-19. It notes that current treatments are not fully effective and an oral drug is needed that can cure early infections. The company, AntiRNA, plans to develop drugs that interfere with viral RNA methylation, an approach they have previously used successfully against other viruses. Their proposed approach involves first synthesizing and testing prototype drugs in vitro and in vivo in Phase 1, then synthesizing derivatives and testing them in Phase 2. If successful, the potential market could be in billions annually given the lack of existing treatments. The company founders have extensive experience in antiviral drug development.
COVID-19 Vaccine FAQ
The document addresses common questions and concerns about the COVID-19 vaccine. It explains that the vaccine was developed quickly but safely by conducting research concurrently instead of consecutively. It also clarifies that the vaccine will not make people sick with COVID-19 or contain tracking microchips. Side effects are explained to be mild like fever and pain at the injection site. The vaccine is deemed safe and effective for diverse populations.
India's COVID-19 Vaccination Drive
In this, various various used in India against COVID has been explained along with the entire vaccination drive of India in 2021.
Coronavirus Pandemic Part III (B): Therapeutic Options
In this section of the coronavirus pandemic series, we discuss the current capacity of local healthcare systems and the need for effective treatment options as well as the pathogenesis of the coronavirus. Current treatment options include RNA, monoclonal antibodies (mAb), antibodies, convalescent plasma, and others. Critical stage implications such as cytokine storm and the need for immunomodulatory agents would also be discussed. Therapeutic pathways would are also compared.
All about Covid-19 Vaccine Development
Disclaimer -
The Content belongs to WHO (World Health Organisation). Sharing here is just to spread awareness about Covid-19.
https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update37-vaccine-development.pdf?sfvrsn=2581e994_6
Covid 19 vaccine_rohimah mohamud
Vaccine development for COVID-19 is a global race against time. Many public and private organizations are working to develop a vaccine, using different approaches like mRNA, DNA, and viral vectors. Malaysia is also involved through collaboration between IMR, MVP and TIDREC to test a vaccine based on previous coronavirus research. The country is also participating in international solidarity trials of potential drug treatments. Locally, blood plasma from recovered patients is being analyzed for antibodies and may help treat other patients. While plasma therapy shows promise, more controlled studies are still needed to confirm efficacy and safety. The development of an effective vaccine remains a high priority in battling the pandemic.
Public perception on COVID-19 Vaccine(AstraZeneca) uptake presentation-Simon ...
This study investigated perceptions of the Covid-19 vaccine and vaccine uptake at the University of Eldoret in Kenya. An online survey was administered to 200 respondents and the data was analyzed using SPSS and Excel. The study found that while most respondents had some knowledge of vaccines, vaccination rates remained low. There were also significant safety concerns and the influence of conspiracy theories. The researchers recommend increasing education efforts through various platforms, with a focus on addressing gender differences, regularly sharing evidence-based research on hesitancy, and integrating immunization programs on campus and in the community.
Covid vaccines pdf - 8 nov 2020
This document provides information on 11 COVID-19 vaccine candidates, including the type of vaccine, number of doses required, status of clinical trials, expected availability, and notes on distribution. Several candidates have preliminary Phase 3 results expected in late 2020 or early 2021, including BNT162b2, AZD1222, mRNA-1273, and NVX-COV2373. Some vaccines like BBIBP-CorV, Coronavac, Ad5-nCoV, and Sputnik V have been approved for emergency use or general populations in some countries despite not having Phase 3 results available yet. Global supply projections range from tens of millions to over a billion doses in 2021 depending on the candidate.
Types of vaccines
Vaccines represent a medical intervention designed to train our defense system by administering weakened or dead versions of pathogens to warn the body so it is ready to fight if the natural version appears. Several vaccines against COVID-19 have been developed and distributed around the world in less than a year, including those using mRNA, DNA, injecting the spike protein, or a dead virus. The different vaccines have efficacy rates from 62-95% and require storage from regular refrigeration to -70°C. While side effects can include pain and fever, the vaccines effectively prevent mortality from COVID-19 and significantly reduce hospitalization.
India Contribute to world.pptx
COVID-19 is a respiratory illness caused by a novel coronavirus (SARS-CoV-2) that emerged in Wuhan, China in late 2019. Symptoms include fever, dry cough, and shortness of breath. The incubation period is up to 14 days. The virus spread rapidly globally within 3 months, infecting over 29 million people worldwide by April 2020. On March 11, 2020, the WHO declared COVID-19 a pandemic due to its worldwide spread and severe health impacts, especially on the elderly and those with preexisting conditions. The pandemic has caused major economic impacts including a projected 4% contraction of global GDP in 2020 and the loss of 225 million full-time jobs.
Top 5 things you should know about any covid 19 vaccine
Everything you need to know about Covid 19 vaccine, different types, special precautions for some people
More Related Content
What's hot
What's in the COVID-19 vaccines?
Description of active and inactive ingredient of COVID-19 vaccine, Pfizer BioNTech, Moderna and AstraZeneca vaccine covered
Coronavirus Pandemic Part III (C): Vaccines (rev01)
In this section of the coronavirus pandemic series, we discuss the need for an effective COVID-19 vaccine to return to full normalcy. The slides would give a brief overview on how our immune systems work, and how a vaccine would train our immune system to recognize and fight the infection. Current vaccine platform technologies will be compared, and upcoming candidates will be highlighted for newer-generation vaccines. We'll also discuss in-depth on factors involving vaccine manufacturing, hesitancy & acceptance, and contingencies. The market capitalization of pharma companies involved in the development of the coronavirus vaccine will also be compared.
Vaccines myths and facts (short)
This document addresses common myths about the COVID-19 vaccine by providing facts. It discusses that most side effects are minor and indicate an immune response is being generated. It also notes that no serious side effects have been reported in the millions vaccinated globally. Additionally, it states that the vaccine development process was not shortened and all usual FDA standards were met, and the mRNA technology used has been studied for over a decade. The document concludes the vaccine is shown to be safe and effective at reducing COVID-19 transmission and chances of catching the virus.
COVID-19 Therapeutics Update (End Q1 2021)
These slides highlight the approved & widely used therapeutics for treating COVID-19 patients (end Q1 2021). At the time of writing, there are 5 therapeutics that have been granted Emergency Use Authorization by the US FDA, mostly being antivirals and monoclonal antibodies (mAbs). The use of corticosteroids and cytokine inhibitors are also showing promise in their ability to reduce case fatalities, progression as well as hospitalization time.
Γρηγόρης Ντάκουλας, 4th Health Innovation Conference
Ομιλία – Παρουσίαση: Γρηγόρης Ντάκουλας, Medical Director AstraZeneca Ελλάδος
Τίτλος: «H AstraZeneca στη μάχη ενάντια στον SARS CoV-2»
SUBTOPIC: COVID- 19 vaccine CRITERIA, BENEFITS
The document summarizes the development process for COVID-19 vaccines. It notes that vaccine development usually takes years but the pandemic spurred over 100 candidates in rapid development. It outlines the typical stages: exploratory research, pre-clinical testing, clinical trials in three phases, regulatory review, quality control, and approval. The document also provides information on COVAXIN, an approved COVID-19 vaccine in India, including its ingredients, administration method, benefits, side effects, and effectiveness based on clinical trials.
Vaccines updates1
There are several types of vaccines in development for COVID-19 because having multiple approaches increases the chances of success. The document discusses live-attenuated, inactivated, subunit, viral vector, and nucleic acid vaccines. Each uses different technologies to prompt an immune response through exposure to part or all of the virus or by delivering genetic instructions for the body to make viral proteins. Understanding the variety of vaccine types being studied can help explain why there are so many candidates under evaluation.
COVID-19 Vaccines Update (End Q1 2021)
These slides highlight the approved & widely used vaccines for immunization against COVID-19 (as of end Q1 2021). At the time of writing, there are 3 COVID-19 vaccines that have been granted Emergency Use Authorization by the US FDA, 2 of which are using mRNA platforms.
Covid 19 Vaccines
In this presentation, we discuss the clinical trial process for the new Covid-19 vaccines. We discuss the different vaccine types. We also discuss the Covid-19 vaccines that the UK is currently using in the NHS, as well as vaccines likely to be used in the next year.
The Future Landscape of Covid-19 Vaccine Market
We believe that assessing the potential market for COVID-
19 vaccines is necessary in terms of reevaluating the risk/reward ratio of certain vaccine developing companies.
In addition, an overly utopian outlook for a potential COVID-19 vaccine market may lead to
disappointment and negatively affect future vaccine developers. And this concerns us more.
Know your COVID-19 Vaccine (Philippines)
The content aims to contribute spreading right information about COVID-19 Vaccine. The information are from World Health Organization and Philippine Department of Health. This may help my fellow Filipino to build his/her confidence to get vaccinated.
Developing Drug against COVID-19
This document discusses developing a new antiviral drug to treat COVID-19. It notes that current treatments are not fully effective and an oral drug is needed that can cure early infections. The company, AntiRNA, plans to develop drugs that interfere with viral RNA methylation, an approach they have previously used successfully against other viruses. Their proposed approach involves first synthesizing and testing prototype drugs in vitro and in vivo in Phase 1, then synthesizing derivatives and testing them in Phase 2. If successful, the potential market could be in billions annually given the lack of existing treatments. The company founders have extensive experience in antiviral drug development.
COVID-19 Vaccine FAQ
The document addresses common questions and concerns about the COVID-19 vaccine. It explains that the vaccine was developed quickly but safely by conducting research concurrently instead of consecutively. It also clarifies that the vaccine will not make people sick with COVID-19 or contain tracking microchips. Side effects are explained to be mild like fever and pain at the injection site. The vaccine is deemed safe and effective for diverse populations.
India's COVID-19 Vaccination Drive
In this, various various used in India against COVID has been explained along with the entire vaccination drive of India in 2021.
Coronavirus Pandemic Part III (B): Therapeutic Options
In this section of the coronavirus pandemic series, we discuss the current capacity of local healthcare systems and the need for effective treatment options as well as the pathogenesis of the coronavirus. Current treatment options include RNA, monoclonal antibodies (mAb), antibodies, convalescent plasma, and others. Critical stage implications such as cytokine storm and the need for immunomodulatory agents would also be discussed. Therapeutic pathways would are also compared.
All about Covid-19 Vaccine Development
Disclaimer -
The Content belongs to WHO (World Health Organisation). Sharing here is just to spread awareness about Covid-19.
https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update37-vaccine-development.pdf?sfvrsn=2581e994_6
Covid 19 vaccine_rohimah mohamud
Vaccine development for COVID-19 is a global race against time. Many public and private organizations are working to develop a vaccine, using different approaches like mRNA, DNA, and viral vectors. Malaysia is also involved through collaboration between IMR, MVP and TIDREC to test a vaccine based on previous coronavirus research. The country is also participating in international solidarity trials of potential drug treatments. Locally, blood plasma from recovered patients is being analyzed for antibodies and may help treat other patients. While plasma therapy shows promise, more controlled studies are still needed to confirm efficacy and safety. The development of an effective vaccine remains a high priority in battling the pandemic.
Public perception on COVID-19 Vaccine(AstraZeneca) uptake presentation-Simon ...
This study investigated perceptions of the Covid-19 vaccine and vaccine uptake at the University of Eldoret in Kenya. An online survey was administered to 200 respondents and the data was analyzed using SPSS and Excel. The study found that while most respondents had some knowledge of vaccines, vaccination rates remained low. There were also significant safety concerns and the influence of conspiracy theories. The researchers recommend increasing education efforts through various platforms, with a focus on addressing gender differences, regularly sharing evidence-based research on hesitancy, and integrating immunization programs on campus and in the community.
Covid vaccines pdf - 8 nov 2020
This document provides information on 11 COVID-19 vaccine candidates, including the type of vaccine, number of doses required, status of clinical trials, expected availability, and notes on distribution. Several candidates have preliminary Phase 3 results expected in late 2020 or early 2021, including BNT162b2, AZD1222, mRNA-1273, and NVX-COV2373. Some vaccines like BBIBP-CorV, Coronavac, Ad5-nCoV, and Sputnik V have been approved for emergency use or general populations in some countries despite not having Phase 3 results available yet. Global supply projections range from tens of millions to over a billion doses in 2021 depending on the candidate.
Types of vaccines
Vaccines represent a medical intervention designed to train our defense system by administering weakened or dead versions of pathogens to warn the body so it is ready to fight if the natural version appears. Several vaccines against COVID-19 have been developed and distributed around the world in less than a year, including those using mRNA, DNA, injecting the spike protein, or a dead virus. The different vaccines have efficacy rates from 62-95% and require storage from regular refrigeration to -70°C. While side effects can include pain and fever, the vaccines effectively prevent mortality from COVID-19 and significantly reduce hospitalization.
What's hot (20)
Coronavirus Pandemic Part III (C): Vaccines (rev01)
Coronavirus Pandemic Part III (C): Vaccines (rev01)
Γρηγόρης Ντάκουλας, 4th Health Innovation Conference
Γρηγόρης Ντάκουλας, 4th Health Innovation Conference
Coronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic Options
Public perception on COVID-19 Vaccine(AstraZeneca) uptake presentation-Simon ...
Public perception on COVID-19 Vaccine(AstraZeneca) uptake presentation-Simon ...
Similar to Pfizer vaccines works on the covid 19 variant found in the india
India Contribute to world.pptx
COVID-19 is a respiratory illness caused by a novel coronavirus (SARS-CoV-2) that emerged in Wuhan, China in late 2019. Symptoms include fever, dry cough, and shortness of breath. The incubation period is up to 14 days. The virus spread rapidly globally within 3 months, infecting over 29 million people worldwide by April 2020. On March 11, 2020, the WHO declared COVID-19 a pandemic due to its worldwide spread and severe health impacts, especially on the elderly and those with preexisting conditions. The pandemic has caused major economic impacts including a projected 4% contraction of global GDP in 2020 and the loss of 225 million full-time jobs.
Top 5 things you should know about any covid 19 vaccine
Everything you need to know about Covid 19 vaccine, different types, special precautions for some people
Covid vaccines
This slide presentation historically, statistically and attractively explains various vaccines for covid19 available in India. (Please update the statistical data to current values)
Legal notice
Our client volunteered for phase 3 trials of the Covishield vaccine at Sri Ramachandra Medical College. He was assured the vaccine was safe based on information provided. However, 11 days after receiving the vaccine, he experienced severe headache, vomiting, altered mental state and was hospitalized. For over a week in the ICU he was disoriented, unable to recognize people, and displayed symptoms of extreme pain. Various tests were unable to determine the cause of his condition. The legal notice is being sent to investigate whether his adverse reaction was caused by the Covishield vaccine.
vaccination
This document summarizes India's strategy for COVID-19 vaccination, which aims to vaccinate its entire population of over 1.3 billion people. It discusses the four main vaccines approved or undergoing clinical trials in India - Covishield, Covaxin, ZyCoV-D, and an unnamed vaccine by Biological E. Limited. The Indian government and manufacturers are working to rapidly increase vaccine production capacity to meet domestic demand and assist other countries.
COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021)
COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021)Thalassaemia International Federation
- The document summarizes information on COVID-19 vaccinations, including details on approved vaccines, global vaccination rates, and the development process for vaccines. It provides data on vaccination rates in different countries and regions. It also compares the Pfizer/BioNTech, Moderna, AstraZeneca/Oxford, and Janssen vaccines, describing their approval status, dosages, efficacy rates, and side effects.FOGSI POSITION STATEMENT COVID VACCINATION FOR PREGNANT & BREASTFEEDING WOMEN
This document discusses recommendations and guidelines regarding COVID-19 vaccination for pregnant and breastfeeding women. It provides information on the current COVID-19 situation globally and in India, the different types of COVID vaccines available in India, benefits of vaccination for the general population and pregnant women, safety of the vaccines for pregnant women, and international recommendations that vaccination should be offered to pregnant women similar to non-pregnant individuals based on risk-benefit analysis. The document concludes by stating current recommendations in India do not support vaccination of pregnant or breastfeeding women due to lack of safety data, but international organizations support vaccination for pregnant women.
covidvaccines-210821171459...........pptx
The document provides information about COVID-19 vaccines in India. It discusses two main vaccines approved for use - Covishield and Covaxin. Covishield is the local version of the Oxford-AstraZeneca vaccine manufactured by the Serum Institute of India. Covaxin is Bharat Biotech's indigenous vaccine developed in collaboration with ICMR. Both vaccines received emergency use approval from the Drugs Controller General of India. The document also provides details on vaccine efficacy, dosing schedules, manufacturing companies, approval process, vaccination coverage trends in India, and strategies to build confidence in COVID-19 vaccines.
Bima oxford-az-vaccine-detailed-position-statement
The British Islamic Medical Association recommends the COVID-19 Vaccine AstraZeneca for eligible individuals in the Muslim community for protection against COVID-19 when used in accordance with regulatory approval. They note efficacy was shown to be 70.42% with mostly mild adverse reactions reported. While vaccines are now available, vigilance with preventive measures like masks and distancing remain important given continued high transmission rates disproportionately impacting ethnic minorities.
Virus Speculation EN
The document discusses several coronavirus vaccine candidates. It notes there are over 210 vaccines in development globally. mRNA vaccines from Moderna and Pfizer-BioNTech are promising candidates, though mRNA technology has never been used in an approved vaccine before. The Pfizer vaccine may be more efficient and easier to produce at scale than Moderna's. Adenovirus vector vaccines like Oxford/AstraZeneca's can be stored at normal refrigeration temperatures and may be easier to distribute. The document speculates on factors that could impact vaccine company stock prices such as clinical trial results, approval timelines, government agreements, and misinformation. It questions Moderna's rapid development timeline given the company has never been profitable.
mRNA Vaccine Official Facts
The document is a fact sheet that provides information about the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine. It describes what is known about COVID-19 and the vaccine, including that it is administered as a two dose series. It outlines both the known benefits of preventing COVID-19 and potential side effects. It provides guidance on what to do after vaccination and how to report any adverse reactions.
Global Impact in Hepatitis-C Market with-In Pakistan and Internationally due ...
The document discusses the global impact of hepatitis C treatment drugs launched by pharmaceutical companies. It provides information on hepatitis C, including key facts about transmission and prevalence in different countries. It analyzes the hepatitis C treatment market globally and regionally, including major players and drug classes. It also discusses the response of different countries like Pakistan, Indonesia, and India to changes in hepatitis C treatment guidelines and availability of generic drugs.
Covid 19 vaccination July 2021
To Enable oneself in India right now on 23 July 2021 onwards about which covid vaccine to consume as they are not interchangable for 2 doses
Generic medicines
Generic medicines are drugs that have the same active ingredients, strength, quality and efficacy as brand name drugs. They must be approved for consumption. The Indian government encourages generic drug manufacturing through policies like allowing process patents and promoting prescriptions by generic drug names. This has made India a leading producer of generic drugs. Generic medicines produced in India are as safe and effective as those produced elsewhere due to stringent global regulations. The government also launched an initiative to make generics more affordable and accessible to all.
Hawaii - American Medical Association - Advancing Science - Ethics and Profes...
Hawaii - American Medical Association - Advancing Science - Ethics and Profes...Clifton M. Hasegawa & Associates, LLC
In every moment, we have two options either to do what is needed or to run away from it. The right thing means nothing but to do what is necessary and feels right to us, by keeping consequences in mind. If you do the right things just because someone is going to reward you, it may make doing the right thing a selfish thing. No matter what situation you are in, you should always do what is right. Doing the right thing only for gaining attention and publicity is unethical. Irrespective of results or benefits, believe in the process, and do the right thing, give justice. Doing the right is itself a reward.
- Shubham Shukla
Poursuite de Public Health and Medical Professionals for Transparency
This document is a complaint filed in a United States District Court against the Food and Drug Administration (FDA). It summarizes that the FDA approved the Pfizer COVID-19 vaccine on August 23, 2021 but questions have been raised publicly about the sufficiency of the data reviewed. The plaintiff, Public Health and Medical Professionals for Transparency (PHMPT), is an organization of public health professionals and scientists that seeks to obtain and disseminate to the public the data relied on by the FDA to license the Pfizer vaccine. PHMPT filed a Freedom of Information Act request with the FDA but their request for expedited processing was denied. The complaint challenges that denial and seeks an order compelling the FDA to produce the responsive records
Antibody cocktail
Presentation by
Primary Information Services
www.primaryinfo.com
mailto:primaryinfo@gmail.com
Download PDF Version at
https://www.slideshare.net/thorapadi/presentations
See Youtube Channel
https://www.youtube.com/user/ch600091/videos?view_as=subscriber
From Startup to Blue Chip: The Success Story of Gilead Sciences Inc.
Gilead Sciences is a biotechnology company founded in 1987 that focuses on antiviral drugs and therapies for HIV, hepatitis B, and influenza. It took several years of operating at a loss through research and development before Gilead obtained its first private financing in 1991 and went public in 1992. Gilead's first drug, Vistide, received FDA approval in 1996. Tamiflu, approved in 1999, became widely used and stockpiled for flu pandemics. More recently, Gilead's drug Sovaldi for hepatitis C achieved a 90% cure rate but also faced controversy over its high $84,000 price for a full treatment. Despite this issue, Gilead has continued to succeed,
Economic and sectoral impact of covid pandemic
Presentation studies the Impact of COVID on Different Sectors of Indian Stock Market. Article observes significant changes in Indian Industrial Sectors in the wake of COVID 19 Pandemic.
Similar to Pfizer vaccines works on the covid 19 variant found in the india (20)
Top 5 things you should know about any covid 19 vaccine
Top 5 things you should know about any covid 19 vaccine
COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021)
COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021)
FOGSI POSITION STATEMENT COVID VACCINATION FOR PREGNANT & BREASTFEEDING WOMEN
FOGSI POSITION STATEMENT COVID VACCINATION FOR PREGNANT & BREASTFEEDING WOMEN
Bima oxford-az-vaccine-detailed-position-statement
Bima oxford-az-vaccine-detailed-position-statement
Global Impact in Hepatitis-C Market with-In Pakistan and Internationally due ...
Global Impact in Hepatitis-C Market with-In Pakistan and Internationally due ...
Hawaii - American Medical Association - Advancing Science - Ethics and Profes...
Hawaii - American Medical Association - Advancing Science - Ethics and Profes...
Poursuite de Public Health and Medical Professionals for Transparency
Poursuite de Public Health and Medical Professionals for Transparency
From Startup to Blue Chip: The Success Story of Gilead Sciences Inc.
From Startup to Blue Chip: The Success Story of Gilead Sciences Inc.
Recently uploaded
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
The Best Ayurvedic Antacid Tablets in India
Treat the symptoms of indigestion, heartburn and stomach reflux with the 10 Best Ayurvedic Antacid Tablets in India.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest VersionArtificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Recently uploaded (20)
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Pfizer vaccines works on the covid 19 variant found in the india
- 2. Pfizer Vaccines Works on the COVID-19 Variant Found in the India Pfizer has confirmed this new by announcing that their vaccine shows high efficacy towards the COVIS-19 variant found in the India. The variant found in India is very deadly has created a havoc in India by surging in the number of cases daily. India touched the maximum number of cases by any country which was more than 400 Thousand per day. Sources has also confirmed that the Pfizer vaccine is also effective children aged above 12, and can be stored safely for a month in a cold storage which temperature ranges between 2-8 degree Celsius. If it secures major regulatory relaxations, such as indemnity, or protection from compensation claims in the event of bad events, the American pharma giant is in talks with the government to fast-track approval and roll out five crore doses between July and October. Covishield, Covaxin, and Sputnik V, the three vaccines currently licensed for use in India, have not been given such protection. Pfizer has insisted on it, and other countries that use the medicine, notably the United States and several European countries, have agreed. Pfizer has shared all the important efficacy data collected from different countries and by WHO. The data obtained are from the UK Public Health England, which reported that the, Pfizer vaccine is 87.9 % efficient towards the B.1.617.2 variant which was reported in India. Link - https://bit.ly/3jGkvRh
- 3. Pfizer Vaccines Works on the COVID-19 Variant Found in the India The variant found in India is very deadly has created a havoc in India by surging in the number of cases daily. India touched the maximum number of cases by any country which was more than 400 Thousand per day.
- 4. About us A Bunch of professional journalists get together to speak the truly powerful word of ‘Pen; we are here to report what’s important and explicit as we “believe that information is for all” For more information please Visit our website:- www.Globalnewsstore.com